approval
saveENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approval
community read0 votes
Sponsor: DAIICHI SANKYO. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvalDec 15, 2025 · 340d ago
- approvalENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvalDec 15, 2025 · 340d ago
- approvalENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvalJan 27, 2025 · 662d ago
- approvalENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvalJan 27, 2025 · 662d ago
- approvalENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvalApr 5, 2024 · 959d ago
- approvalENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvalFeb 15, 2024 · 1009d ago
- approvalENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvalNov 4, 2022 · 1477d ago
- approvalENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI) — FDA approvalAug 5, 2022 · 1568d ago
comments(0)
5-min edit window · permanent after that